Form 13-F position report Filing season in progress

BIOGEN INC

Reported by Old North State Wealth Management LLC

BIIB CUSIP 09062X103 Manager CIK 0002041262

Reported 24,136 shares, down 584 (2.4%) from the prior quarter.

Reported value 2.1%; share count -2.4% vs. the prior quarter.

Reduced
% of reported 13F value 2.26% This manager · Q3 2026
Shares 24,136 Quarter-end amount reported
Reported value $5,451,986 Fair value at quarter end
Consecutive quarters held 20 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 1739420
2022-03-31 1714284
2022-06-30 2009218
2022-09-30 2548249
2022-12-31 2616245
2023-03-31 2703470
2023-06-30 2926738
2023-09-30 2656107
2023-12-31 2899430
2024-03-31 2659720
2024-06-30 3114191
2024-09-30 2623364
2024-12-31 2365313
2025-03-31 2723753
2025-06-30 2540021
2025-09-30 3119532
2025-12-31 4190266
2026-03-31 4509123
2026-06-30 5341146
2026-09-30 5451986

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for BIOGEN INC held by Old North State Wealth Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 24,136 -584 (-2.4%) 2.26% $5,451,986 2026-10-22
Q2 2026 Added 24,720 +125 (0.5%) 2.28% $5,341,146 2026-07-17
Q1 2026 Added 24,595 +786 (3.3%) 2.09% $4,509,123 2026-04-17
Q4 2025 Added 23,809 +1,540 (6.9%) 1.97% $4,190,266 2026-01-23
Q3 2025 Added 22,269 +2,045 (10.1%) 1.46% $3,119,532 2025-10-17
Q2 2025 Added 20,224 +320 (1.6%) 1.32% $2,540,021 2025-07-16
Q1 2025 Added 19,904 +4,437 (28.7%) 1.52% $2,723,753 2025-04-24
Q4 2024 Added 15,467 +1,934 (14.3%) 1.33% $2,365,313 2025-01-27
Q3 2024 Added 13,533 +100 (0.7%) 1.47% $2,623,364 2024-10-29
Q2 2024 Added 13,433 +1,099 (8.9%) 2.05% $3,114,191 2024-10-29
Q1 2024 Added 12,334 +1,130 (10.1%) 1.74% $2,659,720 2024-10-29
Q4 2023 Added 11,204 +870 (8.4%) 2.14% $2,899,430 2024-10-28
Q3 2023 Added 10,334 +60 (0.6%) 2.33% $2,656,107 2024-10-28
Q2 2023 Added 10,274 +551 (5.7%) 2.56% $2,926,738 2024-10-28
Q1 2023 Added 9,723 +276 (2.9%) 2.53% $2,703,470 2024-10-28
Q4 2022 Reduced 9,447 -96 (-1.0%) 2.63% $2,616,245 2024-10-25
Q3 2022 Reduced 9,543 -308 (-3.1%) 2.94% $2,548,249 2024-10-25
Q2 2022 Added 9,851 +1,712 (21.0%) 2.29% $2,009,218 2024-10-25
Q1 2022 Added 8,139 +890 (12.3%) 1.71% $1,714,284 2024-10-25
Q4 2021 New 7,249 +7,249 (0.0%) 1.75% $1,739,420 2024-10-24

Who else reported the position

474 managers reported BIOGEN INC for Q3 2026 so far.

Managers reporting BIOGEN INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
DIMENSIONAL FUND ADVISORS LP Added 1,158,052 +9,484 0.05% $261,588,689 54 qtrs
Pictet Asset Management Holding SA Reduced 832,444 -19,375 0.18% $188,229,218 13 qtrs
Citigroup Inc Added 746,858 +12,341 0.05% $168,700,285 54 qtrs
Robeco Institutional Asset Management B V Reduced 656,465 -134,627 0.18% $148,282,315 54 qtrs
Artemis Investment Management LLP Added 581,774 +10,800 1.15% $131,411,111 4 qtrs
Candriam S C A Added 412,472 +28,146 0.42% $93,509,583 48 qtrs
B Metzler seel Sohn & Co AG Added 403,636 +391,378 0.79% $91,173,300 20 qtrs
Sumitomo Mitsui Trust Holdings Inc Reduced 336,692 -9,925 0.04% $76,051,989 54 qtrs
Swedbank AB Added 322,494 +1,872 0.06% $72,844,943 23 qtrs
KBC Group NV Added 289,080 +10,428 0.14% $65,298,000 54 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
October 22, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
0
Shared
0
None
24,136

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.